A primary infection of peritoneal macrophage cultures with the lactate dehydrogenase-elevating virus (LDV) results in productive infection of 3 to 20% of the cells. When cultures were incubated in the absence of macrophage growth factor (MGF), LDV production ceased after a single cycle, but in cultures in which macrophage replication was stimulated by the presence of MGF LDV production continued for several weeks at a low level, representing not more than 1% of that observed during the acute phase. Significant amounts of interferon were not present in either acutely or persistently infected cultures, and treatment of persistently infected cultures with anti-interferon globulin or superinfection with LDV did not significantly stimulate LDV replication. Macrophage cultures established with peritoneal macrophages from LDV-infected mice also showed only a low level of LDV replication and were resistant to superinfection by LDV. Mouse hepatitis virus, Semliki Forest virus and vesicular stomatitis virus, on the other hand, replicated normally in LDV-persistently infected macrophage cultures. LDV replication was relatively resistant to interferon whether added to the cultures or generated endogenously by infection with Newcastle disease virus or defective-interfering (DI) particles of vesicular stomatitis virus. Temperature-sensitive mutants or DI particles of LDV were not detected in LDV-persistently infected cultures or chronically infected mice. The results support our hypothesis that the decrease in LDV production in mice or macrophage cultures at the end of the acute phase results from the destruction of the subpopulation of macrophages that is permissive for LDV, and that the low level persistent infection involves the passage of the virus to new permissive cells that are generated continuously, although at a low rate, from non-permissive precursor cells.
BoreckyL.,
LackovicV.,
FuchsbergerN.,
HajnickaV.1974; Stimulation of interferon production in macrophages. In Activation of Macrophages pp 111–121 Edited by
WagnerW. H.,
HahnH.
Amsterdam: Excerpta Medica;
De MaeyerE.,
De Maeyer-GuignardV.1979; Interferons. In Comprehensive Virology vol 15 pp 205–284 Edited by
Fraenkel-ConratH.,
WagnerR. R.
New York: Plenum Press;
DoyleM.,
HollandJ. J.1973; Prophylaxis and immunization in mice by use of virus-free defective T particles protect against intracerebral infection by vesicular stomatitis virus. Proceedings of the National Academy of Sciences of the United States of America 70:2105–2108
Du BuyH.,
BaronS.,
UhlendorfC.,
JohnsonM. L.1973; Role of interferon on murine lactic dehydrogenase virus infection, in vivo and in vitro. Infection and Immunity 8:977–984
FullerF. J.,
MarcusP. I.1980a; Interferon production by viruses. IV. Sindbis virus: early passage defective-interfering particles induce interferon. Journal of General Virology 48:63–73
FullerF. J.,
MarcusP. I.1980b; Interferon induction by viruses. V. Sindbis virus: defective interfering particles temperature-sensitive for interferon induction. Journal of General Virology 48:391–394
KumanishiT.1967; Brain tumors induced by Rous sarcoma virus, Schmidt-Rupin strain. 1. Induction of brain tumors in adult mice with Rous sarcoma cells. Japanese Journal of Experimental Medicine 37:461–474
LucasA.,
FlintoffW.,
AndersonR.,
PercyD.,
CoulterM.,
DalesS.1977; In vivo and in vitro models of demyelinating disease: tropism of the JHM strain of murine hepatitis virus for cells of glial origin. Cell 12:553–560
MartinezD.,
WolanskiB.,
TytellA. A.,
DevlinR. G.1979; Viral etiology of age-dependent polioencephalomyelitis in C58 mice. Infection and Immunity 23:133–139
NishiyamaY.,
ItoY.,
ShimokataK.1978; Properties of the viruses selected during persistent infection of L cells with VSV. Journal of General Virology 40:481–484
PeaseL. R.,
MurphyW. H.1980; Co-infection of lactic dehydrogenase virus and C -type retrovirus elicits neurological disease. Nature, London 286:398–400
PlagemannP. G. W.,
SwimH. E.1966; Propagation of lactic dehydrogenase-elevating virus in cell culture. Proceedings of the Society for Experimental Biology and Medicine 121:1147–1152
PlagemannP. G. W.,
WatanabeW.,
SwimH. E.1962; Plasma lactic dehydrogenase-elevating agent of mice: effect on levels of additional enzymes. Proceedings of the Society for Experimental Biology and Medicine 111:749–754
PlagemannP. G. W.,
GregoryK. F.,
SwimH. E.,
ChanK. K. W.1963; Plasma lactic dehydrogenase-elevating virus of mice:distribution in tissues and effect on lactic dehydrogenase isozyme patterns. Canadian Journal of Microbiology 9:75–86
RamseurJ. M.,
FriedmanR. M.1978; Prolonged infection of L cells with vesicular stomatitis virus. Defective interfering forms and temperature sensitive mutants as factors in the infection. Virology 85:253–261
SchmaljohnC. S.,
BlairC. D.1979; Clonal analysis of mammalian cell cultures persistently infected with Japanese encephalomyelitis virus. Journal of Virology 31:816–822
StueckemannJ. A.,
RitziD. M.,
HolthM.,
SmithM. S.,
SwartW. J.,
CafrunyW. A.,
PlagemannP. G. W.1982; Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication. Journal of General Virology 59:245–262
TongS. L.,
StueckemannJ.,
PlagemannP. G. W.1977; Autoradiographic method for detection of lactate dehydrogenase-elevating virus-infected cells in primary mouse macrophage cultures. Journal of Virologv 22:219–227
Van Der GroenG.,
Van Den BerghD. A. R.,
PattynS. R.1976; Interaction of mouse peritoneal macro phages with different arboviruses in vitro. Journal of General Virology 34:353–361
WelshR. M.,
OldstoneM. B.1977; Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression. Journal of Experimental Medicine 145:1449–1468
YoungnerJ. S.,
PrebleO. T.,
JonesE. V.1978; Persistent infection of L cells with vesicular stomatitis virus: evolution of virus populations. Journal of Virology 28:6–13